Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 5, 2021CellsOpen Access

Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

GSGlen Lester SequieraUniversity of British ColumbiaASAbhay SrivastavaSt. Boniface HospitalKAKeshav Narayan AlagarsamySt. Boniface Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sequiera et al. (2021) studied this question.

synapsesocial.com/papers/6aa3f3dfe7e1fc23507493d8https://doi.org/10.3390/cells10030568
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Induced pluripotent stem cell line UOMi002-A from a patient with Leigh syndrome with compound heterozygous mutations in the NDUFV1 gene2020 · 13 citations
  2. 2Mitochondrial disease in adults: what's old and what's new?2015 · 132 citations
  3. 3Relationship Between the Efficacy of Cardiac Cell Therapy and the Inhibition of Differentiation of Human iPSC-Derived Nonmyocyte Cardiac Cells Into Myofibroblast-Like Cells2018 · 14 citations
  4. 4Mitochondrial deficits in human iPSC-derived neurons from patients with 22q11.2 deletion syndrome and schizophrenia2019 · 106 citations